People living with mental health conditions deserve the highest standards of safe, effective, life-saving treatment. We are a Public Benefit Corporation accelerating technology and research to ensure access to care for patients of all backgrounds.
Mental health disorders are one of the leading causes of death and disability worldwide, impacting more than 1 in 4 people each year.
Clinicians are in need of more “evidence-based pharmacotherapy” for powerful treatments such as ketamine, which have shown significant outcomes such as rapid reduction of suicidal ideation
American Journal of Psychiatry
Real-world evidence can ”accelerate medical product development and bring new innovations and advances faster and more efficiently to the patients who need them.”
To empower clinicians and researchers to bring innovative mental health treatments to patients who need it most.
We are scientists, technologists, psychiatrists, and other mission-driven professionals passionate about generating new evidence-based medicine to improve the lives of people with moderate to severe mental health conditions. As a Public Benefit Corporation, Osmind is committed to supporting the development of new, effective treatments for moderate to severe mental health conditions, and to ensure access to care for patients of all backgrounds. We achieve this through rigorous research, advocacy, and modern technology that will most effectively help the medical community advance breakthrough therapies.
Lucia Huang, MBA
Co-founder and CEO
Jimmy Qian, MS
Co-founder and President
Former CEO & Chairman, Allergan
Justin Kao, JD, MBA, MS
Partner, DFJ Growth
Maurizio Fava, MD
Psychiatrist-in-Chief, Massachusetts General Hospital
Robin Carhart-Harris, PhD
Ralph Metzner Distinguished Professor of Neurology and Psychiatry, UCSF
Charles DeBattista, MD
Professor of Psychiatry, Director of the Depression Research Clinic, Stanford
Boris Heifets, MD, PhD
Assistant Professor of Anesthesiology, and by courtesy Psychiatry, Stanford
Carolyn Rodriguez, MD, PhD
Associate Dean, Office of Academic Affairs at Stanford University School of Medicine
Andrew Penn, MS, PMHNP
Clinical Professor at UC San Francisco, School of Nursing
Awais Aftab, MD
Clinical Assistant Professor of Psychiatry at Case Western Reserve University
Bergina Isbell, MD
CMO at Led Life Concierge Psychiatry
Charles Miller MSA, CRNA
Founder and CMO at Scenic City Neurotherapy
Christy Duan, MD
Clinical Assistant Professor, NYU Grossman School of Medicine & Private Practice Psychiatrist
David Feifel, MD, PhD
Founder of Kadima Neuropsychiatry Institute
Erick Sheftic, MD
Co-Founder at Accelerated Psychiatry
Jacob Behrens, MD
Founder of Envision ADHD
Michael Banov, MD
Medical Director of Psych Atlanta
Raghu Appasani, MD
Integrative Psychiatrist & Psychotherapist at Appasani MD PC
Rebecca W. Brendel, M.D., J.D
Immediate Past President of the American Psychiatric Association (APA)
Robert Dugger, MD
Owner & Founder of Sarasota Minds
Sofia Peeva, MD
Co-founder & COO at Propel Therapeutics
Tobias Marton, MD, PhD
Chief Medical Officer at Mindful Health Solutions
Co-founder and past President & CEO of Verana Health; Operating Partner at Linden Capital Partners
CFO at Sophia Genetics; previously COO and CFO at Click Therapeutics, Senior Managing Director & Partner, Equity Research at Evercore
Founder of Syapse
Join our team supporting clinicians and researchers advancing life-saving treatments for people living with mental health conditions.
If you, or someone you know, is in crisis or needs immediate assistance, please call 911 immediately. To talk to someone now, please call the National Suicide Prevention Lifeline at 1-800-273-8255.
Osmind Inc. © 2023 All Rights Reserved.